18 results
RIPE Therapy - Drug Regimens for Microbiologically Confirmed Pulmonary Tuberculosis - IDSA Guidelines

#Tuberculosis #ActiveTB #RIPE #Therapy
RIPE Therapy - Drug ... - IDSA Guidelines ... #Tuberculosis ... #ActiveTB #RIPE ... #medications #pharmacology
Doses of Antituberculosis Drugs for Adults and Children - IDSA
First-line drugs:
 • Isoniazid
 • Rifampin
 •
Antituberculosis Drugs ... and Children - IDSA ... First-line drugs ... Moxifloxacin #Tuberculosis ... #management #pharmacology
Summary table of mechanism of action, side effect and contraindications of commonly used drugs for tuberculosis.
commonly used drugs ... for tuberculosis ... #pharmacology #medications ... table #management #overview ... #tuberculosis
IDSA - Doses of Drugs for Treatment of Adults and Children with Multidrug-Resistant Tuberculosis
Step 1 Levofloxacin,
IDSA - Doses of ... Drugs for Treatment ... antimicrobials #pharmacology ... #dosing #idsa # ... drugs
Linezolid (Zyvox) (PO and IV) - Antibiotics Class Overview

Mechanism: Oxazolidinone class –unique ribosomal inhibitor (acts on
Antibiotics Class Overview ... Also has good activity ... vs tuberculosis ... infections #Pharmacology ... Antibiotics #Review #Overview
Daptomycin  - Antibiotics Class Overview

Mechanism: Lipopeptide antibiotic – forms transmembrane channels and depolarizes cells.
Antibiotics Class Overview ... Rapidly cidal drug ... gram negative activity ... cidal nature) #Pharmacology ... Antibiotics #Review #Overview
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... Resistant Tuberculosis ... MultiDrugResistant #Tuberculosis ... antimicrobials #regimens #pharmacology ... #dosing #idsa #
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Tuberculosis Overview ... Risk Factors For Active ... inhibitors • Injection drug ... Active: Symptomatic ... Treatment: Active
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Tuberculosis Overview ... Risk Factors For Active ... inhibitors • Injection drug ... Active: Symptomatic ... Treatment: Active
Vancomycin and Dalbavancin (lipoglycopeptide antibiotics) - Antibiotics Class Overview

Mechanism: Glycopeptide -  inhibits cell wall synthesis
Antibiotics Class Overview ... positive agent with activity ... Drug of choice for ... #Pharmacology #Antibiotics ... #Review #Overview